It’s pretty interesting to see who genomics luminary J. Craig Venter deems worthy of partnership.
Venter just announced he’s working with AstraZeneca as part of a massive genomics initiative: Company-wide, the pharma giant is going to use data insights from a huge swath of genomes to inform the future of its drug development.
